Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Lingen

Showing results (51-60 of 153) with videos related to

Pageof 16
Sort By:
The British Journal of Oral & Maxillofacial Surgery|January 15, 2013
Journal alliance to address issues of dual submission and plagiarismPeter A Brennan, Jörg Wiltfang, Nabil Samman, et al.
The American Journal of Pathology|January 12, 2002
Neuropilin-1 participates in wound angiogenesisAnnette M Matthies, Quentin E H Low, Mark W Lingen, et al.
Oral Oncology|May 10, 2026
Artificial intelligence model predicts malignant transformation of oral leukoplakia and optimizes interventionsAlessandro Villa, Douglas E Peterson, Mark W Lingen, et al.
Growth Factors (Chur, Switzerland)|November 14, 2014
Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibitionBenjamin D Ferguson, Maria S Tretiakova, Mark W Lingen, et al.
Chembiochem : a European Journal of Chemical Biology|November 13, 2003
Synthetic peptides derived from the angiostatin K4 domain inhibit endothelial cell migrationMonica Dettin, Silvio Bicciato, Claudia Scarinci, et al.
The Cochrane Database of Systematic Reviews|July 20, 2021
Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesionsTanya Walsh, Richard Macey, Alexander R Kerr, et al.
Cancer Research|February 5, 2003
Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progressionRifat Hasina, Kevin Hulett, Silvio Bicciato, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 28, 2010
Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesisGuolin Zhou, Rifat Hasina, Kristen Wroblewski, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 2, 2009
ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesisRifat Hasina, Leslie E Martin, Kristen Kasza, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 2012
A novel Peptide to treat oral mucositis blocks endothelial and epithelial cell apoptosisXiaoyan Wu, Peili Chen, Stephen T Sonis, et al.
Pageof 16

Showing results (51-60 of 153) with videos related to

Sort By:
Pageof 16
The British Journal of Oral & Maxillofacial Surgery|January 15, 2013
Journal alliance to address issues of dual submission and plagiarismPeter A Brennan, Jörg Wiltfang, Nabil Samman, et al.
The American Journal of Pathology|January 12, 2002
Neuropilin-1 participates in wound angiogenesisAnnette M Matthies, Quentin E H Low, Mark W Lingen, et al.
Oral Oncology|May 10, 2026
Artificial intelligence model predicts malignant transformation of oral leukoplakia and optimizes interventionsAlessandro Villa, Douglas E Peterson, Mark W Lingen, et al.
Growth Factors (Chur, Switzerland)|November 14, 2014
Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibitionBenjamin D Ferguson, Maria S Tretiakova, Mark W Lingen, et al.
Chembiochem : a European Journal of Chemical Biology|November 13, 2003
Synthetic peptides derived from the angiostatin K4 domain inhibit endothelial cell migrationMonica Dettin, Silvio Bicciato, Claudia Scarinci, et al.
The Cochrane Database of Systematic Reviews|July 20, 2021
Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesionsTanya Walsh, Richard Macey, Alexander R Kerr, et al.
Cancer Research|February 5, 2003
Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progressionRifat Hasina, Kevin Hulett, Silvio Bicciato, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 28, 2010
Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesisGuolin Zhou, Rifat Hasina, Kristen Wroblewski, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 2, 2009
ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesisRifat Hasina, Leslie E Martin, Kristen Kasza, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 2012
A novel Peptide to treat oral mucositis blocks endothelial and epithelial cell apoptosisXiaoyan Wu, Peili Chen, Stephen T Sonis, et al.
Pageof 16